1. Home
  2. TCBI vs ADMA Comparison

TCBI vs ADMA Comparison

Compare TCBI & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCBI

Texas Capital Bancshares Inc.

HOLD

Current Price

$96.74

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.98

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBI
ADMA
Founded
1996
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TCBI
ADMA
Price
$96.74
$19.98
Analyst Decision
Hold
Strong Buy
Analyst Count
10
2
Target Price
$87.50
$28.50
AVG Volume (30 Days)
417.7K
3.1M
Earning Date
01-22-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
2948.16
205.35
EPS
6.10
0.86
Revenue
$1,149,977,000.00
$488,559,000.00
Revenue This Year
$47.92
$22.19
Revenue Next Year
$7.89
$24.33
P/E Ratio
$15.89
$23.34
Revenue Growth
39.14
27.63
52 Week Low
$59.37
$13.50
52 Week High
$96.98
$25.67

Technical Indicators

Market Signals
Indicator
TCBI
ADMA
Relative Strength Index (RSI) 72.92 72.29
Support Level $92.40 $19.13
Resistance Level $94.32 $20.22
Average True Range (ATR) 2.36 0.78
MACD 0.58 0.12
Stochastic Oscillator 97.35 94.49

Price Performance

Historical Comparison
TCBI
ADMA

About TCBI Texas Capital Bancshares Inc.

Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: